Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-023674-39-AT
EUCTR2010-023674-39-AT
Active, not recruiting
Not Applicable

Evaluation of a standardized treatment regimen for acromegaly: A multi centre intervention study - Treatment for Acromegaly

Österreichisches Akromegalie Register0 sitesJuly 9, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsSomatuline AutogelSandostatin LARDostinexSomavert

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Österreichisches Akromegalie Register
Status
Active, not recruiting
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 9, 2014
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Österreichisches Akromegalie Register

Eligibility Criteria

Inclusion Criteria

  • •1\. All patients with diagnosed but untreated or inadequately treated acromegaly attending the study centres
  • •(specialized outpatient departments) in Austria will be asked to participate in this study. Patients will be included
  • •independent of previous treatments for acromegaly including surgery and/or radiation as well as no surgery due
  • •to patients wish or inoperability.
  • •2\. Age \=18 yrs.
  • •3\. MRI of the Sellaregion not older than 6 months prior to study entry
  • •4\. Written informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • •1\. Patients on Pegvisomant at the time of inclusion
  • •2\. Previous treatment or interruption of treatment with Pegvisomant due to lack of effect
  • •3\. Known hypersensitivity or intolerance to Pegvisomant or the components of its pharmacological preparation
  • •4\. Pregnancy or lactation
  • •5\. Active liver disease (ASAT and ALAT \>3x ULN)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 3
Evaluation of a standard treatment regimen of anti-tuberculosis drugs for patients with MDR-TB
CTRI/2017/09/009693The international Union Against Tuberculosis and lung diseases
Completed
Not Applicable
Evaluation of the treatment standard: Treatment of severe acute lung injury by extracorporeal membrane oxygenatiosevere acute respiratory distress syndrome
DRKS00013967niversitätsmedizin Mannheim24
Not yet recruiting
Not Applicable
Evaluation of a standardized therapy regimen in early rehabilitation for ICU acquired weakness - Early-CIP StudyG62.8Other specified polyneuropathies
DRKS00033177Cellitinnen Krankenhaus St. Marien124
Not yet recruiting
Not Applicable
Mangement of Bleeding from gums through Ayurvedic treatment protocolHealth Condition 1: null- Patients Suffering from Shonitanugami Shitad
CTRI/2018/06/014536Govt Akhandanand ayurved College
Not yet recruiting
Not Applicable
Evaluation of the therapeutic success of a standardized analgesic concept in order to treat postoperative pain after surgery of the head and neck in the Department of Otorhinolaryngology - Head & Neck Surgery of the University of ErlangeJ35.0C14.0Chronic tonsillitisPharynx, unspecified
DRKS00016517HNO-Klinik Universitätsklinikum Erlangen100